BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that the results from a Phase III clinical trial for its ALTACE® (ramipril) diuretic combination product will be presented at the American Society of Hypertension’s Twenty-Second Annual Scientific Meeting in a poster on Saturday, May 19, 2007 at the Hyatt Regency Hotel, Chicago, Illinois. The poster presentation will be available for review from 10 AM to 6 PM CDT. The Company previously announced that it has positive top-line results from the clinical trial evaluating the efficacy and safety of the Company’s ALTACE® diuretic combination product in the treatment of hypertension.
